No records
|
291 |
37067234900 |
Noto Dwimartutie |
Dr.dr. Noto Dwimartutie, SpPD-KGer. |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Frailty and Its Associated Risk Factors: First Phase Analysis of Multicentre Indonesia Longitudinal Aging Study |
Setiati S., Soejono C.H., Harimurti K., Dwimartutie N., Aryana I.G.P.S., Sunarti S., Budiningsih F., Mulyana R., Dwipa L., Sudarso A., Rensa R., Istanti R., Azwar M.K., Marsigit J. |
Frontiers in Medicine |
|
Q1 |
|
|
291 |
14325991900 |
Siti Setiati |
Prof. Dr. dr. Siti Setiati, SpPD-KGer, M.Epid, FINASIM |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Frailty and Its Associated Risk Factors: First Phase Analysis of Multicentre Indonesia Longitudinal Aging Study |
Setiati S., Soejono C.H., Harimurti K., Dwimartutie N., Aryana I.G.P.S., Sunarti S., Budiningsih F., Mulyana R., Dwipa L., Sudarso A., Rensa R., Istanti R., Azwar M.K., Marsigit J. |
Frontiers in Medicine |
|
Q1 |
|
|
291 |
23473513200 |
Kuntjoro Harimurti |
Dr. dr. Kuntjoro Harimurti, Sp.P.D-KGer., M.Sc. |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Frailty and Its Associated Risk Factors: First Phase Analysis of Multicentre Indonesia Longitudinal Aging Study |
Setiati S., Soejono C.H., Harimurti K., Dwimartutie N., Aryana I.G.P.S., Sunarti S., Budiningsih F., Mulyana R., Dwipa L., Sudarso A., Rensa R., Istanti R., Azwar M.K., Marsigit J. |
Frontiers in Medicine |
|
Q1 |
|
|
291 |
24472241900 |
Czeresna Heriawan Soejono |
Dr. dr. Czeresna Heriawan Soejono, Sp.PD., K.Ger., M.Epid. |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Frailty and Its Associated Risk Factors: First Phase Analysis of Multicentre Indonesia Longitudinal Aging Study |
Setiati S., Soejono C.H., Harimurti K., Dwimartutie N., Aryana I.G.P.S., Sunarti S., Budiningsih F., Mulyana R., Dwipa L., Sudarso A., Rensa R., Istanti R., Azwar M.K., Marsigit J. |
Frontiers in Medicine |
|
Q1 |
|
|
No records
|
593 |
57207819540 |
Supri Irianti Handayani |
Dra. Supri Irianti Handayani, M.Biomed |
Departemen Patologi Anatomik |
Pendidikan Dokter (S1) |
Fsh receptor and ki-67 protein expressions of endometrial macaque in mid-luteal phase after exposure to various doses of recombinant fsh and fixed-dose of gnrh agonist |
Sahar N., Birowo P., Thuffi R., Muharram A.R., Ode Z.W., Subahar R., Yazid F., Handayani S.I., Prasasty V.D. |
OnLine Journal of Biological Sciences |
|
Q4 |
|
|
593 |
57207890516 |
Fatmawaty |
Dra. Fatmawaty, M.Si |
Departemen Kimia |
Pendidikan Dokter (S1) |
Fsh receptor and ki-67 protein expressions of endometrial macaque in mid-luteal phase after exposure to various doses of recombinant fsh and fixed-dose of gnrh agonist |
Sahar N., Birowo P., Thuffi R., Muharram A.R., Ode Z.W., Subahar R., Yazid F., Handayani S.I., Prasasty V.D. |
OnLine Journal of Biological Sciences |
|
Q4 |
|
|
593 |
6504153311 |
Ponco Birowo |
Prof. dr. Ponco Birowo, Sp.U., Ph.D. |
Departemen Urologi |
Urologi (Sp-1) |
Fsh receptor and ki-67 protein expressions of endometrial macaque in mid-luteal phase after exposure to various doses of recombinant fsh and fixed-dose of gnrh agonist |
Sahar N., Birowo P., Thuffi R., Muharram A.R., Ode Z.W., Subahar R., Yazid F., Handayani S.I., Prasasty V.D. |
OnLine Journal of Biological Sciences |
|
Q4 |
|
|
593 |
57212464367 |
Nurhuda Sahar |
|
|
Ilmu Biomedik (S2) |
Fsh receptor and ki-67 protein expressions of endometrial macaque in mid-luteal phase after exposure to various doses of recombinant fsh and fixed-dose of gnrh agonist |
Sahar N., Birowo P., Thuffi R., Muharram A.R., Ode Z.W., Subahar R., Yazid F., Handayani S.I., Prasasty V.D. |
OnLine Journal of Biological Sciences |
|
Q4 |
|
|
593 |
57212475033 |
Rosalina Thuffi |
|
|
Ilmu Biomedik (S2) |
Fsh receptor and ki-67 protein expressions of endometrial macaque in mid-luteal phase after exposure to various doses of recombinant fsh and fixed-dose of gnrh agonist |
Sahar N., Birowo P., Thuffi R., Muharram A.R., Ode Z.W., Subahar R., Yazid F., Handayani S.I., Prasasty V.D. |
OnLine Journal of Biological Sciences |
|
Q4 |
|
|